News

Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders
Gilead Sciences, Inc. (NASDAQ: GILD) and Kymera Therapeutics, Inc. (NASDAQ: KYMR), today announced that they have entered ...
Vietnam Recommerce Market Report 2025: Forecast to 2029 - Vietnam's Recommerce Market to Reach USD 1.97 Billion at an 11.3% CAGR
The report delivers a data-rich overview of Vietnam’s recommerce landscape, analyzing over 60 KPIs. It explores peer-to-peer ...
Sean 'Diddy' Combs trial: Prosecution and defense rest; Combs says he won't testify
The prosecution and defense rested their cases in Sean 'Diddy' Combs' sex trafficking trial after 29 days of testimony.